Ozempic vs. Wegovy: Which Works Better for Your Weight Loss Goals?

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic and Wegovy are identical medications containing semaglutide, a GLP-1 receptor agonist that slows stomach emptying and reduces appetite. The primary difference lies in their FDA-approved indication: Ozempic targets type 2 diabetes, while Wegovy is labeled specifically for weight management. Clinical trials show semaglutide users lose 15–22% of body weight over 68 weeks, making it one of the most effective weight loss tools available today.

Understanding the Semaglutide Difference: Ozempic vs. Wegovy

Ozempic and Wegovy are manufactured by the same company and contain identical semaglutide formulations. The distinction is purely regulatory: Ozempic received FDA approval as a diabetes medication, while Wegovy underwent a separate approval pathway for chronic weight management. Both medications work through the same biological mechanism—activating GLP-1 receptors in the brain to suppress hunger signals and improve blood sugar control.

Insurance coverage often determines which medication patients receive. Ozempic may be covered for diabetic patients, while Wegovy coverage for weight loss remains inconsistent and heavily depends on plan design. This coverage gap has driven many patients toward compounded semaglutide options, which offer the same active ingredient at transparent, flat monthly pricing without insurance requirements.

How Semaglutide Delivers Weight Loss Results

Semaglutide works by mimicking glucagon-like peptide-1, a hormone that regulates appetite and blood sugar. When you inject semaglutide weekly, it activates receptors throughout your digestive system and brain, signaling fullness faster and extending meal satisfaction. Most patients report eating 20–30% less food without conscious restriction, combined with reduced cravings for high-calorie foods.

The PlexusDx Precision Peptide Genetic Test analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to semaglutide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

Cost, Access, and Affordability of Semaglutide Therapy

Brand-name Ozempic and Wegovy often cost $800–$1,200 monthly, with insurance approval uncertain and prior authorizations common. PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan with no insurance required, no membership fees, and HSA/FSA eligibility. Your dose may need to go up as your body responds—your price won't, maintaining consistent cost across all dose escalations.

Compounded semaglutide is manufactured by licensed 503A compounding pharmacies and contains the same active pharmaceutical ingredient as brand formulations. PlexusDx delivers to all 50 states, removing geographic barriers and enabling patients in rural or underserved areas to access precision weight loss therapy. The Precision Peptide Genetic Test ($298) provides personalized insights into your peptide metabolism, helping optimize your treatment plan.

Choosing Between Injection and Oral Semaglutide Options

Semaglutide is available as a weekly injection or daily oral tablet. Injections deliver faster peak blood levels and typically produce stronger appetite suppression, making them ideal for patients seeking maximum weight loss momentum. Oral semaglutide offers convenience for needle-averse patients, though absorption is lower and efficacy slightly reduced compared to injections.

PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan and oral semaglutide at $289/mo (or $249/mo on the 6-month plan), giving you flexibility to match your preferences and lifestyle. Injection patients often see results within 2–3 weeks, while oral formulations may take 4–6 weeks to reach full efficacy. Your PlexusDx provider can guide you toward the delivery method that maximizes adherence and metabolic response based on your goals and medical history.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded semaglutide as effective as brand-name Ozempic or Wegovy?

Yes. Compounded semaglutide from licensed 503A pharmacies contains identical active pharmaceutical ingredients and delivers the same clinical outcomes. The difference is cost and access—PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan without insurance, versus $800–$1,200 for branded versions. Efficacy, potency, and safety profiles are equivalent.

How much weight can I expect to lose with semaglutide?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Can I use compounded semaglutide if I don't have insurance?

Absolutely. PlexusDx requires no insurance, no membership fees, and no prior authorization. Semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, are HSA/FSA eligible, and ship to all 50 states. The flat-rate pricing model means your cost remains stable regardless of dose escalation.

What side effects should I expect from semaglutide?

Common side effects include nausea, vomiting, constipation, and reduced appetite—the latter being therapeutic for weight loss. Most side effects peak during the first 2–4 weeks and diminish as your body adjusts. Serious adverse events are rare; report severe abdominal pain, pancreatitis signs, or persistent vomiting to your healthcare provider immediately.

How does the Precision Peptide Genetic Test personalize my semaglutide therapy?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy For Weight Loss 2
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Wegovy Weight Loss Pills

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.